SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

Core Insights - Sera Prognostics, Inc. will present at the TD Cowen 46th Annual Health Care Conference on March 2, 2026, focusing on its achievements in maternal and neonatal health [1] - The company specializes in innovative pregnancy biomarker information, particularly through its PreTRM® Test, which predicts the risk of spontaneous preterm birth [1] Company Overview - Sera Prognostics is dedicated to improving maternal and neonatal health through precision pregnancy care [1] - The PreTRM® Test is the only broadly validated, commercially available blood-based biomarker test for early risk prediction of spontaneous preterm birth [1] Preterm Birth Context - Preterm birth is defined as any birth before 37 weeks' gestation and is the leading cause of illness and death in newborns [1] - The 2025 March of Dimes Report Card indicates that the U.S. has received a D+ grade for preterm birth for four consecutive years, marking the longest stretch of the lowest grade in history [1] - The annual healthcare costs for managing complications of prematurity in the U.S. were estimated at approximately $25 billion for 2016 [1] PreTRM® Test Details - The PreTRM Test measures proteins in the blood that are highly predictive of preterm birth, allowing for individualized risk assessment during weeks 18 to 20 of pregnancy [1] - This test enables physicians to make informed clinical decisions based on each woman's individual risk [1]